Showing posts with label pharmaceutical Manufacturing. Show all posts
Showing posts with label pharmaceutical Manufacturing. Show all posts
10/19/12
3/3/11
Good Manufacturing Practices for Pharmaceuticals
Product Description
Good Manufacturing Practices For Pharmaceuticals
Sixth Edition
Edited by Joseph D. Nally
With global harmonization of regulatory requirements and quality standards and national and global business consolidations ongoing at a fast pace, pharmaceutical manufacturers, suppliers, contractors, and distributors are impacted by continual change. Offering a wide assortment of policy and guidance document references and interpretations, this Sixth Edition is significantly expanded to reflect the increase of information and changing practices in CGMP regulation and pharmaceutical manufacturing and control practices worldwide. An essential companion for every pharmaceutical professional, this guide is updated and expanded by a team of industry experts, each member with extensive experience in industry or academic settings.
11/2/10
Biocatalysis for the Pharmaceutical Industry: Discovery, Development, and Manufacturing
Biocatalysis for the Pharmaceutical Industry: Discovery, Development, and Manufacturing.
By Junhua Tao, Guo-Qiang Lin, Andreas Liese
- Publisher: Wiley
- Number Of Pages: 250
- Publication Date: 2008-10-31
- ISBN-10 / ASIN: 0470823143
- ISBN-13 / EAN: 9780470823149
Product Description:
Biocatalysis is rapidly evolving into a key technology for the discovery and production of chemicals, especially in the pharmaceutical industry, where high yielding chemo-, regio-, and enantioselective reactions are critical. Taking the latest breakthroughs in genomics and proteomics into consideration, Biocatalysis for the Pharmaceutical Industry concisely yet comprehensively discusses the modern application of biocatalysis to drug discovery, development, and manufacturing. Written by a team of leading experts, the book offers deep insight into this cutting edge field.
- Covers a wide range of topics in a systematic manner with an emphasis on industrial applications
- Provides a thorough introduction to the latest biocatalysts, modern expression hosts, state-of-the-art directed evolution, high throughput screening, and bioprocess engineering
- Addresses frontier subjects such as emerging enzymes, metabolite profiling, combinatorial biosynthesis, metabolic engineering, and autonomous enzymes for the synthesis and development of chiral molecules, drug metabolites, and semi-synthetic medicinal compounds and natural product analogs
- Highlights the impact of biocatalysis on green chemistry
- Contains numerous graphics to illustrate concepts and techniques
Biocatalysis for the Pharmaceutical Industry is an essential resource for scientists, engineers, and R&D policy makers in the fine chemical, pharmaceutical, and biotech industries. It is also an invaluable tool for academic researchers and advanced students of organic and materials synthesis, chemical biology, and medicinal chemistry.
9/29/10
Handbook of Cosmetic Science and Technology, Third Edition
Handbook of Cosmetic Science and Technology, Third Edition
Edited by a team of experienced and internationally renowned contributors, the updated Third Edition is the standard reference for cosmetic chemists and dermatologists seeking the latest innovations and technology for the formulation, design, testing, use, and production of cosmetic products for skin, hair, and nails.
New features in the Third Edition:
39 new chapters reorganized by skin functions descriptions of ingredients, products, efficacy measurement, and mechanisms in each chapter revised chapters on skin types, skin perception, and targeted products new chapters on skin aging and cosmetics for the elderly strong emphasis on testing and current methods used for testing, and the evolution of instruments for skin and hair testing new ingredients, delivery systems, and testing methodologies information on skin physiology and cosmetic product design interactions affecting and attributed to cosmetic products cosmetic ingredients, vehicles, and finished products difference between pure cosmetics for enhancement and cosmetics used to treat high quality standards in cosmetic products that improve appearance, protect their targets, and maintain natural functions.9/8/10
Good Pharmaceutical Manufacturing Practice: Rationale and Compliance.
John Sharp - Good Pharmaceutical Manufacturing Practice: Rationale and Compliance.
Pages:288 | PDF | Interpharm Press Inc (30. Oktober 2004) | ISBN 0849319943 | 4.5 MB
Bridging the gap between U.S. regulations and European Good Manufacturing Practice guidelines, this book comparatively presents the major substance of both the U.S. Current Good Manufacturing Practice, parts 210 and 211 (US cGMPs) and the European Guide to Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use (EU GMP guide). Based on the author's 40+ years experience, it offers special consideration of the reasoning behind the requirements, with specific regards to compliance methods. Topics also include personnel, documentation, premises and equipment, production, quality control, self-inspection, recalls, and more. This is an essential guidebook for those who wish to expand their pharmaceutical business in any international capacity.
9/5/10
Pharmaceutical Manufacturing Encyclopedia, 3rd Edition
William Andrew Publishing, "Pharmaceutical Manufacturing Encyclopedia, 3rd Edition"
William Andrew Publishing l PDF l 10 MB
William Andrew Publishing l PDF l 10 MB
This industry standard encyclopedia on pharmaceutical manufacturing processes has been completely updated to include FDA drugs approved up to the summer of 2004. The encyclopedia gives details for the manufacture of 2226 pharmaceuticals that are being marketed as a trade-named product somewhere in the world. Each entry includes:
• Therapeutic function
• Chemical and common name
• Structural Formula
• Chemical Abstracts Registry no.
• Trade name, manufacturer, country, and year introduced
• Raw Materials
• Manufacturing Process
In addition, references are also cited under each drug’s entry to major pharmaceutical works where additional information can be obtained on synthesis and the pharmacology of the individual products.














